髓样癌-话题@MedSci - 梅斯（MedSci）

#髓样癌#

19篇内容 | 792人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1822012, encodeId=93f71822012a8, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=Clin Endocrinol：甲状腺髓样癌伴异位库欣综合征的病例研究, objectType=article, longId=294076, objectId=0b122940e643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b122940e643, replyNumber=0, likeNumber=93, createdTime=2022-05-22, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b122940e643, moduleTitle=Clin Endocrinol：甲状腺髓样癌伴异位库欣综合征的病例研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b122940e643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822011, encodeId=5e611822011fa, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JCEM：降钙素原作为甲状腺髓样癌可替代的肿瘤标志物, objectType=article, longId=215929, objectId=45b221592904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45b221592904, replyNumber=0, likeNumber=89, createdTime=2022-03-01, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45b221592904, moduleTitle=JCEM：降钙素原作为甲状腺髓样癌可替代的肿瘤标志物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=45b221592904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822009, encodeId=5dc31822009ff, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=Brit J Surg：甲状腺髓样癌患者术后并发症, objectType=article, longId=203715, objectId=df0c203e15c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c203e15c6, replyNumber=0, likeNumber=102, createdTime=2021-01-02, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c203e15c6, moduleTitle=Brit J Surg：甲状腺髓样癌患者术后并发症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=df0c203e15c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822007, encodeId=8054182200e32, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=NEJM：Selpercatinib用于RET突变甲状腺髓样癌的治疗, objectType=article, longId=199972, objectId=ffdb1999e20f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffdb1999e20f, replyNumber=0, likeNumber=73, createdTime=2021-03-11, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffdb1999e20f, moduleTitle=NEJM：Selpercatinib用于RET突变甲状腺髓样癌的治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ffdb1999e20f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822008, encodeId=c317182200832, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=Brit J Surg：甲状腺髓样癌术后并发症分析, objectType=article, longId=202285, objectId=b4172022851c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4172022851c, replyNumber=0, likeNumber=97, createdTime=2021-01-03, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4172022851c, moduleTitle=Brit J Surg：甲状腺髓样癌术后并发症分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b4172022851c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822010, encodeId=b78818220104e, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌, objectType=article, longId=204111, objectId=394820411175, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=394820411175, replyNumber=0, likeNumber=80, createdTime=2021-01-20, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=394820411175, moduleTitle=FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=394820411175)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822006, encodeId=5204182200679, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JCEM：甲状腺髓样癌患者的骨转移, objectType=article, longId=188446, objectId=131918844651, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131918844651, replyNumber=0, likeNumber=0, createdTime=2020-07-01, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131918844651, moduleTitle=JCEM：甲状腺髓样癌患者的骨转移, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=131918844651)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822004, encodeId=5a651822004db, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=2019 EANM实践指南：PET/CT检查甲状腺髓样癌, objectType=article, longId=179283, objectId=e14c1e928331, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e14c1e928331, replyNumber=0, likeNumber=70, createdTime=2020-08-15, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e14c1e928331, moduleTitle=2019 EANM实践指南：PET/CT检查甲状腺髓样癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e14c1e928331)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822005, encodeId=dfc91822005df, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=RET突变型甲状腺髓样癌：selpercatinib的III期临床试验已开始, objectType=article, longId=185522, objectId=448618552283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=448618552283, replyNumber=0, likeNumber=65, createdTime=2020-10-23, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=448618552283, moduleTitle=RET突变型甲状腺髓样癌：selpercatinib的III期临床试验已开始, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=448618552283)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822003, encodeId=1525182200315, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=安罗替尼治疗甲状腺髓样癌效果令人振奋，未来还有惊喜, objectType=article, longId=168258, objectId=f84b168258c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f84b168258c1, replyNumber=0, likeNumber=0, createdTime=2019-07-04, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f84b168258c1, moduleTitle=安罗替尼治疗甲状腺髓样癌效果令人振奋，未来还有惊喜, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f84b168258c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822002, encodeId=dcaf182200236, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=Thyroid：安罗替尼治疗甲状腺髓样癌II期临床研究结果在国际权威杂志发表, objectType=article, longId=147648, objectId=0b0214e648e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b0214e648e1, replyNumber=0, likeNumber=86, createdTime=2019-06-05, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b0214e648e1, moduleTitle=Thyroid：安罗替尼治疗甲状腺髓样癌II期临床研究结果在国际权威杂志发表, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0b0214e648e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822001, encodeId=2fdb182200126, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=CLIN CANCER RES：Vandetanib治疗晚期儿童和青少年甲状腺髓样癌的长期疗效, objectType=article, longId=130700, objectId=ad92130e0094, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad92130e0094, replyNumber=0, likeNumber=83, createdTime=2018-03-03, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad92130e0094, moduleTitle=CLIN CANCER RES：Vandetanib治疗晚期儿童和青少年甲状腺髓样癌的长期疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad92130e0094)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821999, encodeId=16b6182199929, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JCEM：除了降钙素，它也可以评估甲状腺髓样癌预后？, objectType=article, longId=108107, objectId=107d10810e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=107d10810e6f, replyNumber=0, likeNumber=77, createdTime=2017-09-15, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=107d10810e6f, moduleTitle=JCEM：除了降钙素，它也可以评估甲状腺髓样癌预后？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=107d10810e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1822000, encodeId=452a182200043, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=ANN ONCOL：cabozantinib治疗甲状腺髓样癌患者总生存分析, objectType=article, longId=121893, objectId=01e312189326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01e312189326, replyNumber=0, likeNumber=88, createdTime=2017-12-18, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01e312189326, moduleTitle=ANN ONCOL：cabozantinib治疗甲状腺髓样癌患者总生存分析, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=01e312189326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821998, encodeId=80f218219985d, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JAMA Surg：甲状腺髓样癌TNM分期方法研究, objectType=article, longId=103391, objectId=600d10339106, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=600d10339106, replyNumber=0, likeNumber=85, createdTime=2017-11-28, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=600d10339106, moduleTitle=JAMA Surg：甲状腺髓样癌TNM分期方法研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=600d10339106)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821997, encodeId=c6ef182199e96, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JCEM：甲状腺髓样癌患者的骨转移和骨骼相关事件研究, objectType=article, longId=78543, objectId=9ebee8543d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ebee8543d2, replyNumber=0, likeNumber=62, createdTime=2017-03-13, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ebee8543d2, moduleTitle=JCEM：甲状腺髓样癌患者的骨转移和骨骼相关事件研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9ebee8543d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821996, encodeId=2eeb182199647, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=Thyroid：索拉非尼治疗晚期甲状腺髓样癌有效性和安全性评价, objectType=article, longId=63440, objectId=23a36344036, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23a36344036, replyNumber=0, likeNumber=92, createdTime=2016-09-26, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23a36344036, moduleTitle=Thyroid：索拉非尼治疗晚期甲状腺髓样癌有效性和安全性评价, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=23a36344036)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821995, encodeId=8efa1821995f0, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=JCO:Cabozantinib显著改善甲状腺髓样癌生存, objectType=article, longId=24255, objectId=5e7f2425596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e7f2425596, replyNumber=0, likeNumber=85, createdTime=2014-05-21, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e7f2425596, moduleTitle=JCO:Cabozantinib显著改善甲状腺髓样癌生存, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5e7f2425596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821994, encodeId=218f1821994bb, content=<a href='/topic/show?id=26091021157a' target=_blank style='color:#2F92EE;'>#髓样癌#</a>, objectTitle=FDA批准cabozantinib用于治疗甲状腺髓样癌, objectType=article, longId=12099, objectId=ae9712099e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae9712099e3, replyNumber=0, likeNumber=76, createdTime=2013-08-30, rootId=0, userName=Boyinsh, userId=726030, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae9712099e3, moduleTitle=FDA批准cabozantinib用于治疗甲状腺髓样癌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ae9712099e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

髓样癌

2020-05-29

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

Clin Endocrinol：甲状腺髓样癌伴异位库欣综合征的病例研究

2022-05-22

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JCEM：降钙素原作为甲状腺髓样癌可替代的肿瘤标志物

2022-03-01

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

Brit J Surg：甲状腺髓样癌患者术后并发症

2021-01-02

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

NEJM：Selpercatinib用于RET突变甲状腺髓样癌的治疗

2021-03-11

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

Brit J Surg：甲状腺髓样癌术后并发症分析

2021-01-03

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

FDA批准RET抑制剂pralsetinib新适应症！治疗甲状腺髓样癌

2021-01-20

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JCEM：甲状腺髓样癌患者的骨转移

2020-07-01

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

2019 EANM实践指南：PET/CT检查甲状腺髓样癌

2020-08-15

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

RET突变型甲状腺髓样癌：selpercatinib的III期临床试验已开始

2020-10-23

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

安罗替尼治疗甲状腺髓样癌效果令人振奋，未来还有惊喜

2019-07-04

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

Thyroid：安罗替尼治疗甲状腺髓样癌II期临床研究结果在国际权威杂志发表

2019-06-05

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

CLIN CANCER RES：Vandetanib治疗晚期儿童和青少年甲状腺髓样癌的长期疗效

2018-03-03

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JCEM：除了降钙素，它也可以评估甲状腺髓样癌预后？

2017-09-15

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

ANN ONCOL：cabozantinib治疗甲状腺髓样癌患者总生存分析

2017-12-18

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JAMA Surg：甲状腺髓样癌TNM分期方法研究

2017-11-28

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JCEM：甲状腺髓样癌患者的骨转移和骨骼相关事件研究

2017-03-13

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

Thyroid：索拉非尼治疗晚期甲状腺髓样癌有效性和安全性评价

2016-09-26

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

JCO:Cabozantinib显著改善甲状腺髓样癌生存

2014-05-21

Boyinsh (审核中...)

前往app查看评论内容

#髓样癌#

FDA批准cabozantinib用于治疗甲状腺髓样癌

2013-08-30

科室
- - 订阅+
  - 更多科室
工具
服务